ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Recipient LAG3 Deficiency Results in Antibody-Mediated Rejection of Mouse Renal Allografts

M. Nicosia, R. Fan, J. Lee, V. Gorbacheva, A. Beavers, N. Dvorina, W. M. Baldwin III, R. L. Fairchild, B. Min, A. Valujskikh

Inflammation and Immunity, Cleveland Clinic, Cleveland, OH

Meeting: 2020 American Transplant Congress

Abstract number: D-350

Keywords: Alloantibodies, B cells, Kidney transplantation

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session D: Lymphocyte Biology: Signaling, Co-Stimulation, Regulation

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • B Cell-Specific IRE1a Deficiency Protects Renal Allografts from Rejection via Inhibition of Donor-Specific Antibodies and Induction of B Regulatory Cells
  • Antibody-Mediated Rejection of Renal Allografts by CCR5-/- Mice Does Not Require CD8 T Cells

*Purpose: Lymphocyte activation gene-3 (LAG3) is a coinhibitory receptor on the surface of T and B lymphocytes, NK cells and plasmacytoid dendritic cells. Its functions in T cells are well studied, however its role in humoral immune responses remains poorly characterized and there have been few studies on the role of LAG3 in transplantation.The goal of this study was to test the role of recipient LAG3 in a mouse model of renal allograft rejection

*Methods:

*Results: Compared to WT animals, naïve B6.LAG3-/-mice exhibit a modest increase in splenic cellularity with T cell pool skewed toward central and effector memory cells and have increased numbers of both foxp3- and foxp3+CXCR5hi follicular T cells. The numbers of B220+CD138+plasma cells were significantly increased in the spleen of LAG3 deficient mice whereas other B cell subsets were not altered. Despite this phenotype LAG3-/-mice do not develop spontaneous autoimmunity without antigen challenge.IFNγELISPOT assay demonstrated that naïve B6.LAG3-/-(H-2Db) mice have increased frequencies of preexisting memory T cells reactive against BALB/c (H-2Dd), SJL (H-2Ds), DBA (H-2Dq) and C3H (H-2Dk) alloantigens. C3H kidney allografts were transplanted into B6.WT or B6.LAG3-/-recipients after bilateral nephrectomy. Whereas 4 out of 4 WT recipients accepted C3H allografts for longer than 60 d, recipient LAG3 deficiency led to rapid allograft rejection (MST of 14 d, n=5) with serum creatinine levels of 0.1 and 1.35 mg/dl respectively at d14 posttransplant (<0.4 mg/dl in non-transplanted mice).

Graft histology at d14 demonstrated decreased T cell infiltration in LAG3-/-vs WT recipients. However, we observed diffuse intragraft C4d staining, atrophic peritubular capillaries, endothelial swelling and edema characteristic of antibody mediated rejection. Compared to WT, LAG3-/-recipients had elevated frequencies of anti-donor IFNγproducing T cells measured by ELISPOT and increased levels of donor MHC-II (I-Ak) specific antibodies measured by ELISA at 14d posttransplant. Depleting recipient CD8 T cells did not alter the rejection kinetics in LAG3-/- recipients (MST of 16 d). In contrast, B cell depletion significantly extended C3H kidney allograft survival (MST of >100 d).

*Conclusions: Taken together, these results suggest the predominant role of alloantibody rather than T cells in renal allograft injury and identify LAG3 is a potential therapeutic target for the prevention and treatment of antibody mediated rejection.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Nicosia M, Fan R, Lee J, Gorbacheva V, Beavers A, Dvorina N, III WMBaldwin, Fairchild RL, Min B, Valujskikh A. Recipient LAG3 Deficiency Results in Antibody-Mediated Rejection of Mouse Renal Allografts [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/recipient-lag3-deficiency-results-in-antibody-mediated-rejection-of-mouse-renal-allografts/. Accessed March 7, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.